Accepted at 4:28 p.m. Dec, 17, 2025 by mmatheso
Author: arkurchin
Related Note: 1520377567174
Rationale for change

The prompt is ambiguously worded and makes it sound like raloxifene is first-line for postmenopausal osteoporosis, which is not true. Rephrased prompt for clarity. Made "extra" a little clearer with more information.

First line therapy source: https://www.uptodate.com/contents/overview-of-the-management-of-low-bone-mass-and-osteoporosis-in-postmenopausal-women?sectionName=Choice%20of%20initial%20therapy&topicRef=145467&anchor=H1289346&source=bqp#H1289346

Source for factoid about raloxifene only prophylaxing against vertebral fractures: https://www.openevidence.com/ask/c2a12983-b1d3-4cef-9ba3-94faad28c9ad

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
UWorld
Empty field
PancePrepPearls
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
!PANCE::PANCE-MSK::Rheumatologic_disorders::Osteoporosis !EOR::FM::FM_MSK OLD_TAGS_EOR-Deck::OBGYN OLD_TAGS_EOR-Deck::female_repro !EOR::OB/GYN::GYN::HealthMaintenance::Postmenopausal::Osteoporosis